In the aspect of somatic mutation frequency, patients in the high‐level cluster had a higher frequency of somatic mutations in KMT2D (Figure 4A and Table S2), which has been reported to sustain prostate carcinogenesis and metastasis.44, 45. This evidence concerns the gene KMT2D and urogenital neoplasm.